These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3093566)

  • 1. Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens.
    Kelley VE; Naor D; Tarcic N; Gaulton GN; Strom TB
    J Immunol; 1986 Oct; 137(7):2122-4. PubMed ID: 3093566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
    Mouzaki A; Volk HD; Osawa H; Diamantstein T
    Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal by interferon-gamma of inhibition of delayed-type hypersensitivity induction by anti-CD4 or anti-interleukin 2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role of the CD4+ TH1+ subset in mice.
    Diamantstein T; Eckert R; Volk HD; Kupier-Weglinski JW
    Eur J Immunol; 1988 Dec; 18(12):2101-3. PubMed ID: 2905998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antigen-specific DTH-initiating cell clone. Functional, phenotypical, and partial molecular characterization.
    Herzog WR; Millet I; Ferreri NR; Ramabhadran R; Schreurs J; Askenase PW
    J Immunol; 1990 May; 144(10):3667-76. PubMed ID: 1970589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.
    Volk HD; Josimovic-Alasevic O; Gross M; Diamantstein T
    Clin Exp Immunol; 1989 Apr; 76(1):121-5. PubMed ID: 2786777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
    Gutstein NL; Wofsy D
    J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
    Malek TR; Chan C; Glimcher LH; Germain RN; Shevach EM
    J Immunol; 1985 Sep; 135(3):1826-33. PubMed ID: 3926885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.
    Osawa H; Diamantstein T
    J Immunol; 1984 May; 132(5):2445-50. PubMed ID: 6425405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to Schistosoma mansoni infections in inbred rats. VII. Resistance is contingent on OX-8(+)-regulated high affinity IL-2 receptor-bearing W3/25+ lymphocytes but not on IL-4-dependent cells.
    Phillips SM; Perrin PJ; Tung AS; Lin JJ; Diamantstein T; Galal N
    J Immunol; 1991 Jul; 147(1):330-6. PubMed ID: 1904903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
    Wofsy D; Mayes DC; Woodcock J; Seaman WE
    J Immunol; 1985 Sep; 135(3):1698-701. PubMed ID: 3160776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements.
    Howe RC; MacDonald HR
    J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    Cua DJ; Coffman RL; Stohlman SA
    J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.